Viewing Study NCT03640403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2026-02-25 @ 9:40 PM
Study NCT ID: NCT03640403
Status: COMPLETED
Last Update Posted: 2024-11-20
First Post: 2018-08-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania
Sponsor: National Institute for Medical Research, Tanzania
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria,Falciparum View
None Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malaria View
None school children View
None randomized controlled trial View
None safety View
None effectiveness View
None Dihydroartemisinin-piperaquine View
None cognitive View
None Artesunate-amodiaquine View
None malaria serology View
None drug resistance View